Antinol: What the Research Really Says About Joint Supplements for Dogs
- Fit-Pet Physio
- Jan 28
- 4 min read
Beyond that, several high‑quality clinical trials have evaluated how these marine‑based fatty acids stack up against NSAIDs, glucosamine, and other joint supplements.
This blog breaks down the science in a clear, practical way so you can make informed decisions for your dog’s joint health.
🟢 Mussel Powder vs Antinol: Why the Extraction Method Matters
Although both products originate from New Zealand green‑lipped mussels, the way they’re processed leads to major differences in safety, potency, and clinical effect.
1. Heat vs No Heat
Mussel powder is typically produced using heat, freeze‑drying, or air‑drying. Heat damages the therapeutic fatty acids, reducing the anti‑inflammatory benefits.
Antinol uses a patented cold‑extraction process that avoids heat entirely, preserving the full spectrum of active lipids.
2. Stability and Shelf Life
GLM powder oxidises quickly, becoming rancid and losing potency.
Antinol’s oil remains stable for up to 3 years.
3. Purity and Safety
Mussel powder can contain high cadmium levels, which are not removed during processing and may exceed supplement safety limits.
Antinol contains only GLM oil + olive oil, with contaminants removed.
4. Salt and Protein Content
Mussel powder has high salt and 55% protein, increasing the risk of reactions in dogs with seafood allergies.
Antinol contains no protein, making it low‑risk for sensitive dogs.
5. Clinical Evidence
Many GLM powder brands have no published clinical studies.
Antinol has multiple peer‑reviewed trials supporting its use in canine OA.
6. Potency
Research suggests 50 x 500 mg mussel powder tablets equal the active compounds in one 50 mg Antinol capsule.
🐕 What Do Clinical Trials Say About Antinol for Canine Osteoarthritis?
Across several blinded, randomised, placebo‑controlled studies, marine‑based fatty acids — particularly PCSO‑524 (Antinol) and EAB‑277 (Antinol + krill oil) — consistently show measurable benefits for dogs with OA.
Below is a breakdown of the key findings.
🔬 Study 1: Antinol vs 4CYTE vs NSAID vs Placebo
Design:
101 dogs with hip OA
4 groups: Antinol, 4CYTE (Epitalis), meloxicam, placebo
Outcomes measured at weeks 0, 2, 4, 6
Objective measure: Peak Vertical Force (PVF) — gold standard for limb loading
Subjective measure: orthopaedic assessment
Results:
Antinol and meloxicam showed significant improvement in limb use by week 6.
4CYTE showed no difference from placebo.
Improvements in Antinol were similar to meloxicam by weeks 4–6.
All treatments reduced pain scores, but only Antinol and meloxicam improved objective limb function.
Why it matters: Antinol demonstrated clinically meaningful, measurable improvements, not just owner‑reported changes.
🔬 Study 2: Marine Lipids vs Glucosamine/Chondroitin vs Carprofen vs Placebo
Design:
75 dogs with hip OA
5 groups: Antinol, glucosamine/chondroitin, EAB‑277, carprofen, placebo
PVF and orthopaedic scoring at 0, 2, 4, 6 weeks
Results:
Carprofen improved PVF by week 2.
Marine lipids (Antinol and EAB‑277) improved PVF by week 4.
Glucosamine/chondroitin showed only half the improvement in PVF by week 6.
By week 6, marine lipids performed similarly to carprofen.
Orthopaedic scores did not significantly change in any group.
Why it matters: Glucosamine remains popular, but evidence is mixed. Marine lipids consistently outperform it in controlled trials.
🔬 Study 3: Antinol + NSAID vs NSAID Alone
Design:
79 dogs with hip or stifle OA
Groups: NSAID alone, Antinol alone, combination
4‑week study
Results:
All groups improved in PVF.
Combination therapy produced the greatest improvement in weight‑bearing.
Bloodwork showed no adverse effects from Antinol.
NSAID‑only and combination groups showed mild increases in kidney markers, but all remained within normal limits.
Why it matters: Antinol appears safe and may enhance the effect of NSAIDs, allowing for multimodal pain management.
🔬 Safety Study: Marine Lipids in Healthy Dogs
Design:
12 healthy dogs + control group
56‑day feeding trial
Bloodwork every 28 days
Results:
All blood values remained normal
No adverse effects
Marine lipids may even support liver function
Why it matters: Safety is essential for long‑term OA management — and Antinol appears well‑tolerated.
🧭 What Does All This Mean for Dog Owners?
1. Antinol is more potent and stable than mussel powder.
Cold extraction preserves active compounds that heat‑processed powders lose.
2. Antinol has stronger clinical evidence than most GLM powders.
Multiple controlled trials show measurable improvements in mobility and pain.
3. Marine lipids can perform similarly to NSAIDs in some dogs.
They won’t replace NSAIDs for severe OA, but they can be a powerful part of multimodal care.
4. Glucosamine/chondroitin is less reliable.
Still widely used, but evidence is inconsistent compared to marine lipids.
5. Antinol is safe for long‑term use.
Studies show no significant side effects, even at high doses.
🐾 Final Thoughts
Osteoarthritis affects up to 80% of dogs over eight years old, and even young dogs aren’t immune with 40% of dogs aged 8mth - 4years affected too. Managing OA is always multimodal — combining weight control, veterinary physiotherapy, pain relief, and targeted supplements.
Based on current research, Antinol stands out as one of the most evidence‑based natural supplements available, with advantages in potency, safety, and clinical performance over traditional mussel powders.
Get started with Antinol now with 5% off with code MAT8855417
References can all be found here- https://antinolstudies.com/th/
Comments